| Aug 7 |
Here's What Key Metrics Tell Us About Charles River (CRL) Q2 Earnings
|
| Aug 7 |
Charles River drops as biopharma headwinds prompt guidance cut
|
| Aug 7 |
Charles River Laboratories (CRL) Surpasses Q2 Earnings and Revenue Estimates
|
| Aug 7 |
Charles River Laboratories beats top-line and bottom-line estimates; lowers FY24 outlook
|
| Aug 7 |
Charles River: Q2 Earnings Snapshot
|
| Aug 7 |
Charles River Laboratories Announces Second-Quarter 2024 Results
|
| Aug 6 |
Charles River Laboratories Q2 2024 Earnings Preview
|
| Aug 5 |
Unlocking Q2 Potential of Charles River (CRL): Exploring Wall Street Estimates for Key Metrics
|
| Jul 30 |
Charles River Collaborates with Patient Advocacy Group, FOXG1 Research Foundation to Advance Rare Disease Gene Therapy Development
|
| Jul 24 |
Here's How Charles River (CRL) is Placed Ahead of Q2 Earnings
|
